| Porsche Maneice, SLP | |
|
242 St Helens Ave, Tacoma, WA 98402-2514 | |
| (253) 627-3833 | |
| Not Available |
| Full Name | Porsche Maneice |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 242 St Helens Ave, Tacoma, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013698083 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL61458218 (Washington) | Primary |
| Provider Name | Nancy Johnson Speech & Language Ps |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396345401 PECOS PAC ID: 1153734389 Enrollment ID: O20210107002690 |
News Archive
Bright light arouses us. Bright light makes it easier to stay awake. Very bright light not only arouses us but is known to have antidepressant effects. Conversely, dark rooms can make us sleepy. It's the reason some people use masks to make sure light doesn't wake them while they sleep.
With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announces its new Healthland Analytics solution. Developed in partnership with Performance Management Institute (PMI), Healthland Analytics extracts relevant data from the Healthland Financial System solutions and other sources and presents it in easy-to-grasp, actionable snapshots of financial, operational and clinical performance.
BioDelivery Sciences International, Inc. announced that it has entered into a license and supply agreement with Kunwha Pharmaceutical Co., Ltd., for the exclusive rights to develop and commercialize BEMA Fentanyl (marketed as ONSOLIS in the U.S.) in the Republic of Korea. The agreement results in potential milestone payments to BDSI of up to $1,275,000, which includes an upfront payment of $300,000. In addition, BDSI will receive an ongoing royalty based on net sales.
GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Porsche Maneice, SLP 2355 S State St Unit 103, Tacoma, WA 98405-2824 Ph: (205) 260-8878 | Porsche Maneice, SLP 242 St Helens Ave, Tacoma, WA 98402-2514 Ph: (253) 627-3833 |
News Archive
Bright light arouses us. Bright light makes it easier to stay awake. Very bright light not only arouses us but is known to have antidepressant effects. Conversely, dark rooms can make us sleepy. It's the reason some people use masks to make sure light doesn't wake them while they sleep.
With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announces its new Healthland Analytics solution. Developed in partnership with Performance Management Institute (PMI), Healthland Analytics extracts relevant data from the Healthland Financial System solutions and other sources and presents it in easy-to-grasp, actionable snapshots of financial, operational and clinical performance.
BioDelivery Sciences International, Inc. announced that it has entered into a license and supply agreement with Kunwha Pharmaceutical Co., Ltd., for the exclusive rights to develop and commercialize BEMA Fentanyl (marketed as ONSOLIS in the U.S.) in the Republic of Korea. The agreement results in potential milestone payments to BDSI of up to $1,275,000, which includes an upfront payment of $300,000. In addition, BDSI will receive an ongoing royalty based on net sales.
GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S.
› Verified 2 days ago
Andrea Lynn Rottier, LL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4301 S Pine St, Ste 219, Tacoma, WA 98409 Phone: 253-476-6550 | |
Janet Kobayashi-hobson, CCC Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Christine L Camp, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 E 44th St, Tacoma, WA 98404 Phone: 253-571-2908 | |
Ann S Lewis, B.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1202 S 76th St, Tacoma, WA 98408 Phone: 253-571-4579 | |
Angela Curtis, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-7919 | |
Peggy Lesniak, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1310 S Union Ave Ste A100, Tacoma, WA 98405 Phone: 253-383-2423 |